S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Critical asset just had biggest fall on record (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Critical asset just had biggest fall on record (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Critical asset just had biggest fall on record (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Critical asset just had biggest fall on record (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?

Astellas Pharma (ALPMY) Insider Trading & Ownership

$10.98
-0.01 (-0.09%)
(As of 02/28/2024 ET)

There is no recent insider trading on record for Astellas Pharma, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public.

Get ALPMY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Astellas Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Astellas Pharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction
7/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$14.40$15,001 - $50,000
2/27/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Buy$14.09$15,001 - $50,000
1/13/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$14.62$1,001 - $15,000
(Data available from 1/1/2013 forward)












ALPMY Insider Trading Activity - Frequently Asked Questions

Which members of congress are trading Astellas Pharma?

Daniel S. Goldman (D-NY) has sold shares of Astellas Pharma in the last year totaling $32,500.


More Insider Trading Tools from MarketBeat

This page (OTCMKTS:ALPMY) was last updated on 2/29/2024 by MarketBeat.com Staff